The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Another fantastic set of results for this company, great to see the large surplus of cash allowing them to pay out yet another dividend and I think things can only improve from here as they have a clear focus on maintaining their core market whilst investing in what must be a massive opportunity market with the digital offerings.
The amazon listing is working fine
https://www.amazon.co.uk/Pharm2Farm-Pro-Larva-Medical-Grade-Disposable/dp/B08WJP9C51/ref=cm_cr_arp_d_product_top?ie=UTF8
LP
He is a sales director, the main product of P2F's current focus hasn't been ready to materialise any actual orders until very recently. What performance measures would you like to assess him over the past year, given no production of course?
You are correct it was, I thought that's who was being queried.
Even so I personally don't see the issue of 2m options (worth 5k profit at current MP so hardly will be rushing to sell) to two of you employees as anything unusual. They also appear to vest over 3 years which is normal, and is a cash free incentive for your employees to work at improving the share price and overall value of the company.
The agreement p2f have with Volz is actually for the production of both IIR and FFP masks, this machine was never intended for FFP masks. The Volz element for the FFP was confirmed in an RNS about a week or so ago.
As for the gen pop, you're totally right. I believe the advice is against wearing FFP type masks outdoors in general areas which is why the IIR mask being certified was so critical.
The production delay isn't even a factor here, they can now start confirming orders and getting cashflow through the door, the production is just a matter of timing semantics.
The only hold up to verified orders was certification and that is now achieved.
@Parsley2
No your comment is as much an inference as the one you quote. What it literally states is "Whilst interest remains strong. no firms orders have been received as yet with achieving certification an important step for potential customers".
You can interpret this how you will, but my logical conclusion would be that potential customers have raised their interest and specifically stated they want to make orders and will do so once the "important step" of certification has been achieved, i.e. certification achieved and that interest immediately flips into solid orders as the original post also hinted at.
@Jp1959
Nice summary.
One point you left out that I think is quite important that I had not seen being confirmed before. Volz are producing for us both the IIR and FFP masks. This is of massive importance when we discuss the NHS as it means we will have anti-viral masks that suit both standard surgical requirements and cover off the increase in the focus being put on the airborne virus with the FFP masks.
@Cyrox
I wasn't implying anything, and for clarity the head gone comment was in reference to a certain Simpson and not yourself.
I follow you now, I thought you were talking certification rather than quality checks as I suspect we won't see an RNS until the certification has been achieved as that clears the remaining worries of investors. Certification of the 4 ply can (I think) be more readily achieved than the 5 ply and so I again I suspect the 4 ply will be updated on ahead of the 5. Not a negative point by any stretch just a thought. The market to the gen pop might actually prove to be the bigger market after all.
I've seen some head gone moments in my time but this is impressive.
@cyrox
The certification for the 4 ply vs the 5 ply is of differing requirements I believe and the public market would surely be the 4 ply so I think the move to production could be quicker than you anticipate, but otherwise totally agree with your comment regarding not rushing any official announcements as could potentially only hinder further down the line for a quick raise now.
@Tiptree
PR holds no shares but does still hold c. 40m options at 1.4p, can see it on the RNS from 18th Nov
Could this be TB dumping his position (at a significant profit) before the vote for the warrants goes ahead and looks more appealing....
Why would they release an RNS stating it has arrived, it is not material news given they said it had been despatched.
The picture from Twitter that Magnum found, bar being a very very good attempt at a photoshop, is most definitely the same lorry from Lemu's Instagram accounts, and most definitely Biocity in Notts. Just relax and wait for news of production next week.
Can someone explain to me how the late trades work please and what they mean? it's something I have never worked out on here.
@HawkesBay
I don't disagree, but what about the events of the last couple of months makes you think this BoD have any respect for the shareholders?
I expect the warrants to be voted down, don't really see how they can't be at any price over 3...
The lorry has 100% already arrived, that is Biocity in Magnum's photo situated just off the city centre of Notts in Sneinton.
There is zero doubt it has arrived, so why no RNS given all the previous ones on the delays to delivery etc etc.
@Gareth3672
I think a few of us discussed when it was announced to wait and see what happens here once the BRH dividend is paid, which I think it happening in the next day or so.
Will be very interested to see if there are any positive RNS announcements for RMS that accompany the payout....
@Nate-PI
Also a question on you valuation:
We had c. 1.2bn shares at 1.7p = £19.8m
We have 400m shares to come at 1.25p = £5m
We have 420m warrants to come at 2p = £8.4m
Totals c. 2bn shares at a total of £33.2m which equates to 1.7p per share weighted average no? Where did you get 0.709p from?
Obviously this doesn't take account of investor activity/reaction,
@Natte-PI
I may have missed something here, but I thought Gyometric was a subsidiary of RMS, so (albeit most here only seem interested in the P2F masks) any value added to Gyometric through additional investment would still be value inherently added to RMS, or do you see it differently?